SCHEMBL9940955

SCHEMBL9940955

CCOC(=O)C(O)CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1n[nH]c(O)n1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9930504 1.00 MME (0.68) MME
Trifluoroacetic Acid SCHEMBL29583408 0.96 MME (0.63) MME
SCHEMBL9941498 0.88 MME (0.79) MME
SCHEMBL9930054 0.88 MME (0.79) MME
SCHEMBL9929984 0.85 MME (0.69) MME
SCHEMBL9929981 0.85 MME (0.69) MME
SCHEMBL15464273 0.82 MME (0.68) MME
SCHEMBL15464274 0.82 MME (0.68) MME
Trifluoroacetic Acid SCHEMBL29583914 0.81 MME (0.64) MME
SCHEMBL9929456 0.80 MME (0.74) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651896-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2013-10-23 — — EP disclosed
WO-2012082853-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2012-06-21 — — WO disclosed
Send feedback